What is the first line antibiotic for an uncomplicated urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotics for Uncomplicated UTI

Nitrofurantoin 100mg twice daily for 5 days is the recommended first-line antibiotic for uncomplicated urinary tract infections, followed by trimethoprim-sulfamethoxazole and fosfomycin as alternative first-line options. 1

Evidence-Based Recommendations

First-Line Options (in order of preference):

  1. Nitrofurantoin (100mg twice daily for 5 days)

    • Excellent efficacy against common uropathogens
    • Low resistance rates
    • Minimal impact on gut flora
    • Contraindicated if GFR <30 mL/min 1
    • Has shown increasing use due to repositioning as first-line therapy 2
  2. Trimethoprim-sulfamethoxazole (160/800mg twice daily for 3 days)

    • Traditional first-line agent 3
    • FDA-approved for urinary tract infections 4
    • Effective against E. coli and other common uropathogens
    • Consider local resistance patterns before prescribing 3
  3. Fosfomycin (3g single dose)

    • Convenient single-dose administration 5
    • Good activity against resistant pathogens
    • Lower clinical and microbiological cure rates compared to nitrofurantoin 3

Second-Line Options:

  1. Amoxicillin-clavulanic acid

    • Listed as first choice in WHO guidelines 3
    • Use when first-line agents cannot be used
  2. Fluoroquinolones (e.g., ciprofloxacin)

    • Highly efficacious but should be reserved for more serious infections 3
    • Classified as "Watch" antibiotics by WHO due to resistance concerns 1
    • Associated with more serious adverse effects 1
  3. β-Lactams (e.g., cephalexin)

    • Generally inferior efficacy and more adverse effects 3
    • Should be used with caution for uncomplicated cystitis

Important Considerations:

  • Local Resistance Patterns: Consider local resistance rates, particularly for trimethoprim-sulfamethoxazole 3, 6
  • Patient Factors: Consider allergies, pregnancy status, and renal function
  • Antibiotic Stewardship: Reserve fluoroquinolones for more invasive infections 7
  • Treatment Duration: 3-5 days for uncomplicated UTIs 1
  • Contraindications:
    • Avoid nitrofurantoin if GFR <30 mL/min
    • Avoid amoxicillin/ampicillin for empirical treatment due to high resistance rates 3

Algorithm for Selection:

  1. For uncomplicated UTI in otherwise healthy women:

    • Start with nitrofurantoin if GFR >30 mL/min
    • If nitrofurantoin contraindicated → trimethoprim-sulfamethoxazole (if local resistance <20%)
    • If single-dose therapy preferred → fosfomycin
  2. If first-line agents contraindicated:

    • Consider amoxicillin-clavulanic acid or oral cephalosporins
    • Reserve fluoroquinolones for patients with allergies to first-line agents or when other options are unavailable

The evidence clearly supports nitrofurantoin as the optimal first-line choice due to its continued effectiveness against common uropathogens and lower propensity for developing resistance compared to other antibiotics 2, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.